Natural killer cell therapy (Medigen Biotechnology)

N/A

Report date: 2025/05/09 16:49:31

Base Information

Drug NameNatural killer cell therapy (Medigen Biotechnology)

Drug Alias NameAllogeneic Magicell-NK cell TherapyMagicell-NK

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionNatural killer cell replacements

TargetsNot applicable

Therapy Area/IndicationsPancreatic NeoplasmsCholangiocarcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedigen Biotechnology Corp

China Registration ClassN/A

Develop Information

Active CompaniesMedigen Biotechnology Co

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsCholangiocarcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A